methyllycaconitine has been researched along with Chronic Illness in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berez, C; Brotherton, T; Christopher, NC; Davis, K; Levin, ED; Montalvo-Ortiz, J; Perkins, A; Qazi, M; Williams, P | 1 |
Chumley, P; Feng, W; Hua, P; Jaimes, EA; Rezonzew, G; Siegal, GP | 1 |
2 other study(ies) available for methyllycaconitine and Chronic Illness
Article | Year |
---|---|
Chronic underactivity of medial frontal cortical beta2-containing nicotinic receptors increases clozapine-induced working memory impairment in female rats.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Antipsychotic Agents; Cerebral Cortex; Chronic Disease; Clozapine; Dihydro-beta-Erythroidine; Female; Maze Learning; Memory Disorders; Memory, Short-Term; Microinjections; Nicotinic Antagonists; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic | 2009 |
Nicotine exposure and the progression of chronic kidney disease: role of the α7-nicotinic acetylcholine receptor.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Blood Pressure; Chronic Disease; Disease Models, Animal; Disease Progression; Kidney Diseases; Male; NADPH Oxidase 4; NADPH Oxidases; Nephrectomy; Nicotine; Nicotinic Antagonists; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Transforming Growth Factor beta | 2012 |